Get a closer look at the newest development in cancer immunotherapy: the bifunctional fusion protein.

Could this small but mighty protein designed to block two signaling pathways used by tumor cells to escape immune system control be the key to managing both tumor growth and metastasis?

For more episodes in this series, visit ReachMD.com/IO.